Pubblicazioni

Immunotherapy for platinum-resistant ovarian cancer

2020 - GYNECOLOGIC ONCOLOGY

Bogani, G.; Lopez, S.; Mantiero, M.; Ducceschi, M.; Bosio, S.; Ruisi, S.; Sarpietro, G.; Guerrisi, R.; Brusadelli, C.; Dell'Acqua, A.; Di Donato, V.; Raspagliesi, F.

Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?

2019 - GYNECOLOGIC ONCOLOGY

Tomao, F; Musacchio, Lucia; Di Mauro, F; Boccia, Sm; Di Donato, V; Giancotti, A; Perniola, G; Palaia, I; Muzii, L; Benedetti Panici, P

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

2019 - GYNECOLOGIC ONCOLOGY

Daniele, G; Arenare, L; Scambia, G; Pisano, C; Sorio, R; Breda, E; De Placido, S; Savarese, A; Ferrandina, G; Raspagliesi, F; Panici, Pb; Ferro, A; Rimanti, A; Cormio, G; Lorusso, D; Cecere, Sc; Scalone, S; Marsico, Va; Cardalesi, C; Cognetti, F; Salutari, V; Attademo, L; Guizzaro, L; Schettino, C; Piccirillo, Mc; Perrone, F; Gallo, C; Pignata, S

The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis

2018 - GYNECOLOGIC ONCOLOGY

Ruscito, I; Darb-Esfahani, S; Kulbe, H; Bellati, F; Zizzari, Ig; Rahimi Koshkaki, H; Napoletano, C; Caserta, D; Rughetti, A; Kessler, M; Sehouli, J; Nuti, M; Braicu, Ei.